Target intelligence / Profile preview

Potassium channel subfamily K member 1 (KCNK1 (also called TWIK-1))

Target
KCNK1 (also called TWIK-1)
Molecular classification
Ion channel, two-pore domain potassium channel (K2P family), transporter
01

Overview

Potassium channel subfamily K member 1 (KCNK1, also known as TWIK-1) is a membrane protein that belongs to the two-pore domain potassium channel (K2P) family. This protein facilitates passive transmembrane potassium transport and contributes to the regulation of the resting membrane potential, particularly in brain astrocytes and neurons. KCNK1 may not form a functional channel as a homodimer but can form heterodimers with other K2P members, contributing to neuronal excitability and kidney function. Its activity is regulated through mechanisms such as sumoylation and intracellular trafficking. There is no well-established therapeutic agent that targets KCNK1 directly, and it is not currently a common biomarker in clinical use.

Other names
KCNK1TWIK-1TWIK1HOHOHOHO1K2P1K2P1.1DPKKCNO1inward rectifying potassium channel protein TWIK-1potassium two pore domain channel subfamily K member 1potassium channel K2P1potassium channel KCNO1
02

Mechanism of action

No drugs known to act directly on KCNK1/TWIK-1 in clinical use; possible modulation by anesthetics and sumoylation, but insufficient evidence of direct targeting.

03

Biological functions

Regulation of resting membrane potentialPassive transmembrane potassium transportModulation of action potential firing in neuronsRegulation of excitability in neuronsRegulation of ion and water transport in the kidneyRegulation of pancreatic beta cell membrane potential
04

Disease associations

Other (linked to neuronal and kidney physiology; no strong direct disease association with major classes such as cancer or inflammation reported)
05

Safety considerations

Low intrinsic activity as a homodimer; possible functional alteration with heterodimerizationRapid internalization and sumoylation affect channel availabilityPotential impact on neuronal excitability and kidney function if modulated, but no specific adverse effect profile established

Beyond the preview

Go deeper on Potassium channel subfamily K member 1 (KCNK1 (also called TWIK-1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 1 (KCNK1 (also called TWIK-1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call